Telangiectasia

Telangiectasia is an abnormal dilation of small blood vessels, usually capillaries, that appears on the surface of the skin or mucous membranes. These changes can be either integrated into different body systems or localized to specific areas of the body. Telangiectasias are often associated with various conditions and diseases, such as genetic syndromes or post-traumatic changes. Clinically, they appear as bright red or purple lines or spots that can range in size from a few millimeters to several centimeters. It is important to note that telangiectasias are more common in women, especially in conditions of hormonal instability, and can have both cosmetic and medical significance.

History of the disease and interesting historical facts

Telangiectasia as a medical term began to be used in the 18th century, when scientists began to study diseases of the vascular system. One of the first doctors to describe this condition was the Swedish anatomist Carl Linnaeus, who in his works mentioned various types of vascular anomalies. Interestingly, during the 19th century, attention to telangiectasias increased, in particular due to the work of such eminent doctors as Moratz, who studied the effects of systemic diseases associated with telangiectasias. In the 20th century, many associations were established between telangiectasias and hereditary syndromes, which became the basis for further research in the field of genetics and vascular pathology.

Epidemiology

Epidemiological studies show that telangiectasia is a fairly common condition, affecting 20% of the population, although the severity and clinical manifestations can vary significantly. A higher percentage of occurrence is observed in women, especially in middle and old age. According to research, most cases of telangiectasia are associated with hereditary factors, as well as environmental factors such as ultraviolet radiation. For example, studies conducted in Europe and North America note that more than 30% women over 40 years of age have visually pronounced telangiectasias on the skin of the face and lower extremities.

Genetic predisposition to this disease

Studies show that there is a significant genetic predisposition to the development of telangiectasias. Some mutations in genes such as ENG, ACVRL1, and SMAD4 are associated with hereditary syndromes such as Osler-Weber-Rendu syndrome, suggesting that there is a genetic component to the pathogenesis of telangiectasias. These genes are also involved in angiogenesis and the maintenance of vascular integrity. Some patients have congenital forms of telangiectasias, suggesting that abnormal genes can be passed on from parents to children. It is important to note that not all cases of telangiectasias are genetic, and environmental factors also play a significant role.

Risk factors for the development of this disease

Risk factors for telangiectasias can vary and include both physical and chemical exposures. These include:

• Genetic predisposition: having relatives with similar conditions.
• Hormonal changes: pregnancy, menopause, hormone therapy.
• Exposure to UV radiation: prolonged exposure to the sun or visiting solariums.
• Effects of temperature: high or low temperatures, including hypothermia or overheating.
• Skin trauma: repetitive mechanical trauma or surgical interventions.
• Liver diseases: cirrhosis and other pathologies affecting the vascular system.

These factors can contribute to both the primary occurrence of telangiectasias and their progression.

Diagnosis of this disease

Telangiectasias are diagnosed based on the clinical picture and additional studies. The main symptoms include:

• The presence of visible dilation of blood vessels on the skin, often hyperemic and of various shapes.
• Associated complaints of itching or discomfort in the affected area.
• Absence of pain, although soreness may be observed under certain conditions.

Laboratory tests are not necessary for diagnosis, but may be prescribed to exclude other diseases. Radiological tests, such as vascular ultrasound, are used to assess the patency of deep veins and the presence of possible thrombosis. Other diagnostics may include dermatoscopy for a more detailed examination of the vascular condition. Differential diagnosis is important to distinguish telangiectasias from other vascular changes, such as hemangiomas or varicose veins.

Treatment

Treatment of telangiectasias depends on the severity of the condition and the presence of comorbidities. Common approaches include:

• Pharmacological treatment: use of local agents that improve microcirculation and strengthen the vascular wall.
• Surgical treatment: in case of significant aesthetic inconvenience or complications, it is possible to remove the affected areas of skin or use laser therapy.
• Other treatments include sclerotherapy or radiofrequency ablation.

It is important to take into account the individual characteristics of each patient when choosing the most appropriate treatment method.

List of medications used to treat this disease

Medicines used to treat telangiectasias include:

• Venotonics (for example, Detralex) to strengthen the vascular wall.
• Drugs based on rutosides (for example, Troxevasin) to improve venous tone.
• Products containing ascorbic acid to normalize vascular permeability.
• Nonsteroidal anti-inflammatory drugs in the presence of pain syndrome.

The choice of specific drugs should be based on the doctor's recommendation and the individual characteristics of the patient.

Disease monitoring

Monitoring the condition of telangiectasias includes regular examinations by a dermatologist or vascular surgeon. Control stages should be carried out at certain intervals, depending on the characteristics of the course of the disease. The prognosis for most patients is favorable, but complications may arise in the form of thrombophlebitis or secondary infections. Contacting a specialist in the presence of new symptoms or deterioration of the condition is an important condition for preventing complications.

Age-related features of the disease

Age-related features of telangiectasias are manifested in differences in the frequency and severity of the disease in different age groups. In children, telangiectasias can occur as congenital or idiopathic forms without serious clinical significance. In older people, this condition can significantly worsen the quality of life due to aesthetic deficiencies and be associated with manifestations of vascular insufficiency.

Questions and Answers

• What is telangiectasia? Telangiectasia is a dilation of small blood vessels that appears on the skin as red or purple lines.
• What are the main causes of telangiectasia? The main causes include genetic predisposition, hormonal changes and exposure to ultraviolet radiation.
• How is telangiectasias diagnosed? Diagnosis includes visual examination, dermatoscopy and, if necessary, ultrasound examination.
• How is telangiectasias treated? Treatment can be conservative (pharmacological) or surgical (laser therapy, sclerotherapy).
• What is the prognosis for telangiectasias? The prognosis is usually good, but it is important to monitor for changes and see a doctor if new symptoms appear.